125 related articles for article (PubMed ID: 16371895)
1. Ischemic injury-specific gene expression in the rat spinal cord injury model using hypoxia-inducible system.
Lee M; Lee ES; Kim YS; Choi BH; Park SR; Park HS; Park HC; Kim SW; Ha Y
Spine (Phila Pa 1976); 2005 Dec; 30(24):2729-34. PubMed ID: 16371895
[TBL] [Abstract][Full Text] [Related]
2. A hypoxia-inducible gene expression system using erythropoietin 3' untranslated region for the gene therapy of rat spinal cord injury.
Choi BH; Ha Y; Ahn CH; Huang X; Kim JM; Park SR; Park H; Park HC; Kim SW; Lee M
Neurosci Lett; 2007 Jan; 412(2):118-22. PubMed ID: 17178192
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible expression of vascular endothelial growth factor for the treatment of spinal cord injury in a rat model.
Choi UH; Ha Y; Huang X; Park SR; Chung J; Hyun DK; Park H; Park HC; Kim SW; Lee M
J Neurosurg Spine; 2007 Jul; 7(1):54-60. PubMed ID: 17633488
[TBL] [Abstract][Full Text] [Related]
4. Neural stem cells modified by a hypoxia-inducible VEGF gene expression system improve cell viability under hypoxic conditions and spinal cord injury.
Lian Jin H; Pennant WA; Hyung Lee M; Su S; Ah Kim H; Lu Liu M; Soo Oh J; Cho J; Nyun Kim K; Heum Yoon D; Ha Y
Spine (Phila Pa 1976); 2011 May; 36(11):857-64. PubMed ID: 21192293
[TBL] [Abstract][Full Text] [Related]
5. Role of the oxygen-dependent degradation domain in a hypoxia-inducible gene expression system in vascular endothelial growth factor gene therapy.
Jin H; Liu ML; Kim HA; Lee M; An S; Oh J; Cho J; Yi S; Kim K; Yoon D; Ha Y
Spine (Phila Pa 1976); 2009 Dec; 34(26):E952-8. PubMed ID: 20010384
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy with an erythropoietin enhancer-mediated, hypoxia-inducible gene expression system in the corpus cavernosum of mice with high-cholesterol diet-induced erectile dysfunction.
Ryu JK; Lee M; Choi MJ; Kim HA; Jin HR; Kim WJ; Yin GN; Song KM; Kwon MH; Suh JK
J Androl; 2012; 33(5):845-53. PubMed ID: 22403284
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy of neural cell injuries in vitro using the hypoxia-inducible GM-CSF expression plasmids and water-soluble lipopolymer (WSLP).
Kim JM; Lee M; Kim KH; Ha Y; Choi JK; Park SR; Park H; Park HC; Ahn CH; Kim SW; Choi BH
J Control Release; 2009 Jan; 133(1):60-7. PubMed ID: 18938203
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible gene expression system using the erythropoietin enhancer and 3'-untranslated region for the VEGF gene therapy.
Lee M; Choi D; Choi MJ; Jeong JH; Kim WJ; Oh S; Kim YH; Bull DA; Kim SW
J Control Release; 2006 Sep; 115(1):113-9. PubMed ID: 16962197
[TBL] [Abstract][Full Text] [Related]
9. Controlled nonviral gene delivery and expression using stable neural stem cell line transfected with a hypoxia-inducible gene expression system.
Liu ML; Oh JS; An SS; Pennant WA; Kim HJ; Gwak SJ; Yoon DH; Kim KN; Lee M; Ha Y
J Gene Med; 2010 Dec; 12(12):990-1001. PubMed ID: 21157823
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of erythropoietin enhancer-mediated hypoxia-inducible gene expression by co-transfection of a plasmid encoding hypoxia-inducible factor 1alpha for ischemic tissue targeting gene therapy.
Lee S; Kim K; Kim HA; Kim SW; Lee M
J Drug Target; 2008 Jan; 16(1):43-50. PubMed ID: 18172819
[TBL] [Abstract][Full Text] [Related]
11. Sp1-dependent regulation of the RTP801 promoter and its application to hypoxia-inducible VEGF plasmid for ischemic disease.
Lee M; Bikram M; Oh S; Bull DA; Kim SW
Pharm Res; 2004 May; 21(5):736-41. PubMed ID: 15180327
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible vascular endothelial growth factor gene therapy using the oxygen-dependent degradation domain in myocardial ischemia.
Kim HA; Lim S; Moon HH; Kim SW; Hwang KC; Lee M; Kim SH; Choi D
Pharm Res; 2010 Oct; 27(10):2075-84. PubMed ID: 20607367
[TBL] [Abstract][Full Text] [Related]
13. Delivery of hypoxia and glioma dual-specific suicide gene using dexamethasone conjugated polyethylenimine for glioblastoma-specific gene therapy.
Kim HA; Park JH; Yi N; Lee M
Mol Pharm; 2014 Mar; 11(3):938-50. PubMed ID: 24467192
[TBL] [Abstract][Full Text] [Related]
14. Delivery of Hypoxia-Inducible Heme Oxygenase-1 Gene for Site-Specific Gene Therapy in the Ischemic Stroke Animal Model.
Choi M; Oh J; Rhim T; Lee M
Pharm Res; 2016 Sep; 33(9):2250-8. PubMed ID: 27324961
[TBL] [Abstract][Full Text] [Related]
15. The experimental study of hypoxia-inducible factor-1alpha and its target genes in spinal cord injury.
Xiaowei H; Ninghui Z; Wei X; Yiping T; Linfeng X
Spinal Cord; 2006 Jan; 44(1):35-43. PubMed ID: 16044166
[TBL] [Abstract][Full Text] [Related]
16. Efficient gene expression system using the RTP801 promoter in the corpus cavernosum of high-cholesterol diet-induced erectile dysfunction rats for gene therapy.
Lee M; Ryu JK; Piao S; Choi MJ; Kim HA; Zhang LW; Shin HY; Jung HI; Kim IH; Kim SW; Suh JK
J Sex Med; 2008 Jun; 5(6):1355-64. PubMed ID: 18312285
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-specific VEGF-expressing neural stem cells in spinal cord injury model.
Oh JS; An SS; Gwak SJ; Pennant WA; Kim KN; Yoon DH; Ha Y
Neuroreport; 2012 Feb; 23(3):174-8. PubMed ID: 22186804
[TBL] [Abstract][Full Text] [Related]
18. Characterization of neural stem cells modified with hypoxia/neuron-specific VEGF expression system for spinal cord injury.
Yun Y; Oh J; Kim Y; Kim G; Lee M; Ha Y
Gene Ther; 2018 Jan; 25(1):27-38. PubMed ID: 29155421
[TBL] [Abstract][Full Text] [Related]
19. Combined Method of Neuronal Cell-Inducible Vector and Valproic Acid for Enhanced Gene Expression under Hypoxic Conditions.
Yun Y; Baek D; Lee D; Cheong E; Kim J; Oh J; Ha Y
Tissue Eng Regen Med; 2020 Feb; 17(1):55-66. PubMed ID: 32002843
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional and post-translational regulatory system for hypoxia specific gene expression using the erythropoietin enhancer and the oxygen-dependent degradation domain.
Kim HA; Kim K; Kim SW; Lee M
J Control Release; 2007 Aug; 121(3):218-24. PubMed ID: 17628167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
